Most just lately, it has been recognized that conolidine and the above mentioned derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Unlike most opioid receptors, this receptor functions for a scavenger and would not activate